Pancreatic Neuroendocrine Tumor：Factor of Surgery Influencing Survival

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02624154

Enrollment

Registered

2015-12-08

Start date

2015-12-31

Completion date

2016-12-31

Last updated

2015-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Neuroendocrine Tumor

Brief summary

Investigator determined the factor of surgery associated with the survival of pancreatic neuroendocrine tumor.

Detailed description

The variables including clinical characteristics, surgical data and pathological findings are examined by univariate and multivariate analyses.

Interventions

PROCEDUREpancreatectomy

Remove the pancreatic neuroendocrine tumor by surgery

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

10 Years to 80 Years

Healthy volunteers

Inclusion criteria

* The patients with pancreatic neuroendocrine tumor underwent pancreatectomy

Exclusion criteria

* The patients with pancreatic neuroendocrine tumor did not undergo pancreatectomy

Design outcomes

Primary

Measure	Time frame
The survival rate	3 years

Contacts

Primary ContactQinchang Chen, Doctor

337809622@qq.com18819430530

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026